Hematology
Antonio Giordano, M.D., PH.D
Clinical Director, Center for Cancer Therapeutic Innovation; Breast Cancer Pathways Medical Director, Dana-Farber Cancer Institute
Antonio Giordano, MD, PhD, is a breast medical oncologist at Dana-Farber Cancer Institute in Boston, specializing in metastatic breast cancer, particularly hormone receptor-positive (HR+)/HER2-negative cases resistant to standard therapies. He treats a wide range of solid tumors including retroperitoneum cancer, lung cancer, urinary tract cancer, endocrine gland cancer, adrenal gland cancer, anal and rectal cancer, bladder cancer, colon cancer, colorectal cancer, kidney cancer, melanoma, ovarian
22+
Years in Practice
Credentials
Board Certifications
- Medical Oncology, 2019
- Internal Medicine, 2016
Education & Training
- University of Naples Federico II — M.D., 2004
- University of Naples Federico II — PhD, Medical Oncology and Immunology
- Residency, Medical University of South Carolina
- University of Naples Federico II — Oncology Fellowship, 2009
Peer Recognition
- AACR-Bristol-Myers Squibb — Oncology Fellowship in Clinical Cancer Research
2012
- ASCO — Young Investigator Award
2012
- NCI — K12 Paul Calabresi Career Development for Clinical & Translational Oncology Program
2019
Recognition & Leadership
Awards & Honors
- Scholarship award for podium presentation at ASCO Annual Meeting, 2010
- Scholarship award for poster discussion session SABCS, 2010
- ASCO/AACR Clinical Research Workshop Scholarship, 2011
- 2012 AACR-Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research
- ASCO Young Investigator Award, 2012
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
Italian
Experience
22+ years in practice